Skip to content

Multicenter prospective randomized controlled trial for Ge-Jie Ding-Chuan capsules in the treatment of stable COPD patients

Multicenter prospective randomized controlled trial for Ge-Jie Ding-Chuan capsules in the treatment of stable COPD patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067958
Enrollment
Unknown
Registered
2023-02-01
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Experimental group:Ge-Jie Ding-Chuan capsules+Tiotropium bromide
Control group:Tiotropium bromide

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. meeting the diagnostic of COPD, GOLD grade 2 to 3, stable stage. 2. meeting the diagnostic criteria of lung kidney qi yin deficiency syndrom. 3. age 40 to 80 years old, male or female. 4. voluntarily accept the treatment and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who do not meet the above-mentioned Western diagnostic, grading and staging diagnostic and TCM diagnostic criteria. 2. Chronic cough that is confirmed by examination to be caused by tuberculosis, fungi, tumors, irritant gas allergy, etc. 3. Patients with other respiratory diseases that can cause shortness of breath or dyspnea. 4. Pregnant or lactating women, those allergic to tiotropium bromide and mealybug asthma capsules. 5. patients with combined serious primary diseases of the cardiovascular, hepatic, renal and hematopoietic systems, psychiatric patients. 6. patients with serious cardiac insufficiency.

Design outcomes

Primary

MeasureTime frame
TCM Syndrome Effect;CAT;

Secondary

MeasureTime frame
pulmonary function;6MWT;mMRC;BCSS;AE;

Countries

China

Contacts

Public ContactZHANG Wei

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

zhangw1190@sina.com+86 13023153956

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026